Filing Flows › Escalon Medical (ESMC) › Q3 FY26
Escalon Medical (ESMC) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed May 15, 2026
Escalon Medical (ESMC) reported revenue of $2.6M for the third quarter fiscal 2026 (Q3 FY26), -25% from a year earlier and -27% from the quarter before. Operating margin was -16.1%, net earnings $2.4M (91.0% of revenue).
Escalon Medical, Q3 FY26: revenue $2.6M (-25% year over year), operating margin -16.1%, net earnings $2.4M, operating cash flow $281K. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | -27% | -25% |
| Operating profit | −$419K | -525% | -252% |
| Net earnings | $2.4M | 24× | +774% |
| Operating cash flow | $281K | — | +815% |
What changed
Revenue was $2.6M in Q3 FY26, down 25% year over year and down 27% from the previous quarter. Product was the largest line at 95% of revenue. Product lost $843K year over year (down 25%), 97% of the total change.
Operating costs exceeded revenue by $419K, an operating margin of -16.1%. Total costs fell 5% while revenue fell 25%. The fastest-growing cost line was SG&A (+15%). Net earnings were $2.4M, up 774% year over year. The effective tax rate was 0.0%. Non-operating items added $2.8M, 118% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $281K (up 815% year over year), 12% of net earnings. Non-cash charges added back $3K of depreciation and amortization. Working capital and other items used $2.1M.
Questions
What was Escalon Medical's revenue in the third quarter fiscal 2026?
Escalon Medical (ESMC) reported revenue of $2.6M for the third quarter fiscal 2026 (Q3 FY26), -25% from a year earlier and -27% from the quarter before.
Was Escalon Medical profitable in the third quarter fiscal 2026?
Operating loss was $419K (-16.1% of revenue) and net earnings $2.4M.
Source: Escalon Medical 10-Q on SEC EDGAR.